TY - JOUR AU - Hellman, S. AU - Weichselbaum, R. R. PY - 1995 DA - 1995// TI - Oligometastases JO - JCO VL - 13 UR - https://doi.org/10.1200/JCO.1995.13.1.8 DO - 10.1200/JCO.1995.13.1.8 ID - Hellman1995 ER - TY - JOUR AU - MacDermed, D. M. AU - Weichselbaum, R. R. AU - Salama, J. K. PY - 2008 DA - 2008// TI - A rationale for the targeted treatment of oligometastases with radiotherapy JO - J Surg Oncol VL - 98 UR - https://doi.org/10.1002/jso.21102 DO - 10.1002/jso.21102 ID - MacDermed2008 ER - TY - JOUR AU - Pastorino, U. AU - Buyse, M. AU - Friedel, G. PY - 1997 DA - 1997// TI - Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases JO - J Thorac Cardiovasc Surg VL - 113 UR - https://doi.org/10.1016/S0022-5223(97)70397-0 DO - 10.1016/S0022-5223(97)70397-0 ID - Pastorino1997 ER - TY - JOUR AU - Primrose, J. AU - Treasure, T. AU - Fiorentino, F. PY - 2010 DA - 2010// TI - Lung metastasectomy in colorectal cancer: is this surgery effective in prolonging life? JO - Respirology VL - 15 UR - https://doi.org/10.1111/j.1440-1843.2010.01759.x DO - 10.1111/j.1440-1843.2010.01759.x ID - Primrose2010 ER - TY - JOUR AU - Treasure, T. AU - Fallowfield, L. AU - Lees, B. PY - 2012 DA - 2012// TI - Pulmonary metastasectomy in colorectal cancer: the PulMiCC trial JO - Thorax VL - 67 UR - https://doi.org/10.1136/thoraxjnl-2011-200015 DO - 10.1136/thoraxjnl-2011-200015 ID - Treasure2012 ER - TY - JOUR AU - Milano, M. T. AU - Katz, A. W. AU - Schell, M. C. PY - 2008 DA - 2008// TI - Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy JO - Int J Radiat Oncol Biol Phys VL - 72 UR - https://doi.org/10.1016/j.ijrobp.2008.03.044 DO - 10.1016/j.ijrobp.2008.03.044 ID - Milano2008 ER - TY - JOUR AU - Timmerman, R. D. PY - 2008 DA - 2008// TI - An overview of hypofractionation and introduction to this issue of seminars in radiation oncology JO - Semin Radiat Oncol VL - 18 UR - https://doi.org/10.1016/j.semradonc.2008.04.001 DO - 10.1016/j.semradonc.2008.04.001 ID - Timmerman2008 ER - TY - JOUR AU - Rusthoven, K. E. AU - Kavanagh, B. D. AU - Cardenes, H. PY - 2009 DA - 2009// TI - Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.19.6329 DO - 10.1200/JCO.2008.19.6329 ID - Rusthoven2009 ER - TY - JOUR AU - Inoue, T. AU - Katoh, N. AU - Aoyama, H. PY - 2010 DA - 2010// TI - Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions JO - Jpn J Clin Oncol VL - 40 UR - https://doi.org/10.1093/jjco/hyq044 DO - 10.1093/jjco/hyq044 ID - Inoue2010 ER - TY - STD TI - Palma DA, Salama JK, Lo SS, et al. The oligometastatic state - separating truth from wishful thinking. Nat Rev Clin Oncol. 2014;11(9):549–57 ID - ref10 ER - TY - JOUR AU - Rowe, S. P. AU - Tran, P. T. AU - Fishman, E. K. PY - 2017 DA - 2017// TI - Oligoprogression: What radiologists need to know about this emerging concept in cancer therapeutic decision-making JO - Acad Radiol VL - 24 UR - https://doi.org/10.1016/j.acra.2016.12.018 DO - 10.1016/j.acra.2016.12.018 ID - Rowe2017 ER - TY - JOUR AU - Olson, R. A. AU - Howard, F. AU - Lapointe, V. AU - Schellenberg, D. AU - Nichol, A. AU - Bowering, G. AU - Curtis, S. AU - Walter, A. AU - Brown, S. AU - Thompson, C. AU - Bergin, J. AU - Lomas, S. AU - French, J. AU - Halperin, R. AU - Tyldesley, S. AU - Beckham, W. PY - 2018 DA - 2018// TI - Provincial development of a patient-reported outcome initiative to guide patient care, quality improvement, and research JO - Healthc Manage Forum VL - 31 UR - https://doi.org/10.1177/0840470417715478 DO - 10.1177/0840470417715478 ID - Olson2018 ER - TY - JOUR AU - Palma, D. AU - Haasbeek, C. AU - Rodrigues, G. AU - Dahele, M. AU - Lock, M. AU - Yaremko, B. AU - Olson, R. AU - Liu, M. AU - Panarotto, J. AU - Griffioen, G. AU - Gaede, S. AU - Slotman, B. AU - Senan, S. PY - 2012 DA - 2012// TI - Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial JO - BMC Cancer VL - 12 UR - https://doi.org/10.1186/1471-2407-12-305 DO - 10.1186/1471-2407-12-305 ID - Palma2012 ER - TY - STD TI - Palma D, Olson R, Harrow S, Gaede S, Haasbeek CJA, Mulroy L, Lock M, Rodrigues G, Yaremko B, Schellenberg D, Belal A, Griffioen G, Sashendra S, Swaminath A, Kopek N, Liu M, Bauman G, Moore K, Currie S, Louie A, Senan S. Stereotactic ablative radiotherapy versus standard-of-care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomized, phase II, open-label trial. The Lancet. 2018; under revision. ID - ref14 ER -